Home/Filings/4/0001104659-19-041851
4//SEC Filing

Cavan John T 4

Accession 0001104659-19-041851

CIK 0001583771other

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 4:16 PM ET

Size

5.3 KB

Accession

0001104659-19-041851

Insider Transaction Report

Form 4
Period: 2019-07-24
Cavan John T
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2019-07-24+5,8206,059 total
    Exercise: $3.24Exp: 2029-07-24Common Stock (5,820 underlying)
Footnotes (1)
  • [F1]Options vest in three installments as follows: 1,940 options shall vest on each of July 24, 2020, 2021 and 2022.

Documents

1 file

Issuer

Hepion Pharmaceuticals, Inc.

CIK 0001583771

Entity typeother

Related Parties

1
  • filerCIK 0001503738

Filing Metadata

Form type
4
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 4:16 PM ET
Size
5.3 KB